SBIR/STTR Research Award
Rapid Site-Specific Needle-Delivered Adjustable Vessel Occlusion for Control of Junctional And Non-Compressible Hemorrhage
Award amount
$1,492,721Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2022Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- AMSEL MEDICAL CORPORATION
- Proposal award date
- 2022-07-20
- Contract end date
- 2024-02-21
- UEI
- UUM9WLJWJQ24
- Solicitation number
- X20.R
- Topic code
- AF20R-DCSO1
Research abstract
Despite the development of numerous methods for proximal vessel compression and control, even today, the mortality due to exsanguination associated with junctional and non-compressible hemorrhage in the battlefield prior to surgical intervention are extr
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid Site-Specific Needle-Delivered Adjustable Vessel Occlusion for Control of Junctional And Non-Compressible Hemorrhage
- Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A Defect and Damage Inspection Tool for Incoming Part Inspection
- REAFFIRM: Reverse Engineer, Analyze, and Fix Firmware
- Applying Computational Game Theory AI to Many-v-Many BVR Air Combat
- Tetrate TACFI
- Proliferated Geostationary Earth Orbit (GEO) Satellite Communications (SATCOM)
Research funding history
3 SBIR/STTR records share this UEI (2019–2022). Reported award amounts total $2,542,598. Reported amounts are not federal obligations.
Phases: Phase II – Direct to Phase II, Phase I
Agencies: Department of Defense